Your new experience awaits. Try the new design now and help us make it even better

CORRECTION article

Front. Med., 26 June 2025

Sec. Pulmonary Medicine

Volume 12 - 2025 | https://doi.org/10.3389/fmed.2025.1646108

Correction: Bronchoalveolar lavage cell percentages as diagnostic markers of immune checkpoint inhibitor pneumonitis


Mahnoor Mir
&#x;Mahnoor Mir1*Felipe Soto&#x;Felipe Soto2Pedro Antonio Amezcua GomezPedro Antonio Amezcua Gomez2Rodrigo Del Rio ArroyoRodrigo Del Rio Arroyo2Adarsh SureshAdarsh Suresh3Amber SuAmber Su4Qiong GanQiong Gan5John StewartJohn Stewart5Roberto AdachiRoberto Adachi4Diwakar D. BalachandranDiwakar D. Balachandran4Lara BashouraLara Bashoura4Roberto F. CasalRoberto F. Casal4Burton F. DickeyBurton F. Dickey4George A. EapenGeorge A. Eapen4Scott E. EvansScott E. Evans4Horiana GrosuHoriana Grosu4Carlos A. JimenezCarlos A. Jimenez4Julie LinJulie Lin4David E. OstDavid E. Ost4Bruce F. SabathBruce F. Sabath4Vickie R. ShannonVickie R. Shannon4Aung NaingAung Naing6Jianjun GaoJianjun Gao7Jia WuJia Wu8Karthik SureshKarthik Suresh9Saadia A. FaizSaadia A. Faiz4Mehmet Altan&#x;Mehmet Altan10Ajay Sheshadri&#x;Ajay Sheshadri4
  • 1Division of Critical Care, Pulmonary, and Sleep Medicine, McGovern Medical School at UTHealth Houston, Houston, TX, United States
  • 2School of Medicine, Tecnológico de Monterrey, Monterrey, Mexico
  • 3Texas A&M School of Medicine, Houston, TX, United States
  • 4Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States
  • 5Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States
  • 6Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States
  • 7Division of Cancer Medicine, Department of Genitourinary Medical Oncology, Houston, TX, United States
  • 8Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States
  • 9Department of Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, MD, United States
  • 10Department of Thoracic Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States

A Correction on
Bronchoalveolar lavage cell percentages as diagnostic markers of immune checkpoint inhibitor pneumonitis

by Mir, M., Soto, F., Gomez, P. A. A., Arroyo, R. D. R., Suresh, A., Su, A., Gan, Q., Stewart, J., Adachi, R., Balachandran, D. D., Bashoura, L., Casal, R. F., Dickey, B. F., Eapen, G. A., Evans, S. E., Grosu, H., Jimenez, C. A., Lin, J., Ost, D. E., Sabath, B. F., Shannon, V. R., Naing, A., Gao, J., Wu, J., Suresh, K., Faiz, S. A., Altan, M., and Sheshadri, A. (2025). Front. Med. 12:1582714. doi: 10.3389/fmed.2025.1582714

Author Felipe Soto was erroneously not listed as co-first author in the published article. Author Mehmet Altan was erroneously not listed as co-senior author in the published article. The correct author list reads:

Mahnoor Mir1*, Felipe Soto2, Pedro Antonio Amezcua Gomez2, Rodrigo Del Rio Arroyo2, Adarsh Suresh3, Amber Su4, Qiong Gan5, John Stewart5, Roberto Adachi4, Diwakar D. Balachandran4, Lara Bashoura4, Roberto F. Casal4, Burton F. Dickey4, George A. Eapen4, Scott E. Evans4, Horiana Grosu4, Carlos A. Jimenez4, Julie Lin4, David E. Ost4, Bruce F. Sabath4, Vickie R. Shannon4, Aung Naing6, Jianjun Gao7, Jia Wu8, Karthik Suresh9, Saadia A. Faiz4, Mehmet Altan10 and Ajay Sheshadri4

These authors share first authorship

These authors share senior authorship

The Author contributions Statement has been corrected to read:

Author contributions

MM: Writing – original draft, Writing – review & editing, Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Validation, Visualization. FS: Writing – original draft, Writing – review & editing, Data curation, Formal analysis, Investigation, Methodology, Validation, Visualization. PG: Writing – original draft, Writing – review & editing, Data curation. RDA: Writing – original draft, Writing – review & editing, Data curation. AdS: Writing – original draft, Writing – review & editing, Data curation. AmS: Writing – original draft, Writing – review & editing, Data curation. QG: Writing – original draft, Writing – review & editing. JS: Writing – original draft, Writing – review & editing. RA: Writing – original draft, Writing – review & editing. DB: Writing – original draft, Writing – review & editing. LB: Writing – original draft, Writing – review & editing. RC: Writing – original draft, Writing – review & editing. BD: Writing – original draft, Writing – review & editing. GE: Writing – original draft, Writing – review & editing. SE: Writing – original draft, Writing – review & editing. HG: Writing – original draft, Writing – review & editing. CJ: Writing – original draft, Writing – review & editing. JL: Writing – original draft, Writing – review & editing. DO: Writing – original draft, Writing – review & editing. BS: Writing – original draft, Writing – review & editing. VS: Writing – original draft, Writing – review & editing. AN: Writing – original draft, Writing – review & editing. JG: Writing – original draft, Writing – review & editing. JW: Writing – original draft, Writing – review & editing. KS: Writing – original draft, Writing – review & editing. SF: Writing – original draft, Writing – review & editing, Visualization. MA: Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Resources, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing. AS: Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Resources, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing.

The original version of this article has been updated.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: immune check inhibitor (ICI), BAL (bronchoalveolar lavage), lymphocytosis, pneumonitis, eosinophilia, cell percentage

Citation: Mir M, Soto F, Gomez PAA, Arroyo RDR, Suresh A, Su A, Gan Q, Stewart J, Adachi R, Balachandran DD, Bashoura L, Casal RF, Dickey BF, Eapen GA, Evans SE, Grosu H, Jimenez CA, Lin J, Ost DE, Sabath BF, Shannon VR, Naing A, Gao J, Wu J, Suresh K, Faiz SA, Altan M and Sheshadri A (2025) Correction: Bronchoalveolar lavage cell percentages as diagnostic markers of immune checkpoint inhibitor pneumonitis. Front. Med. 12:1646108. doi: 10.3389/fmed.2025.1646108

Received: 12 June 2025; Accepted: 13 June 2025;
Published: 26 June 2025.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2025 Mir, Soto, Gomez, Arroyo, Suresh, Su, Gan, Stewart, Adachi, Balachandran, Bashoura, Casal, Dickey, Eapen, Evans, Grosu, Jimenez, Lin, Ost, Sabath, Shannon, Naing, Gao, Wu, Suresh, Faiz, Altan and Sheshadri. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Mahnoor Mir, bWFobm9vci5taXJAdXRoLnRtYy5lZHU=

These authors share first authorship

These authors share senior authorship

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.